| Dr Jim Mark Ingram, MD | |
|
18 Corporate Hill Dr, Suite 110, Little Rock, AR 72205-4565 | |
| (501) 224-1156 | |
| (501) 801-5561 |
| Full Name | Dr Jim Mark Ingram |
|---|---|
| Gender | Male |
| Speciality | Allergy/immunology |
| Experience | 35 Years |
| Location | 18 Corporate Hill Dr, Little Rock, Arkansas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1093707176 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207K00000X | Allergy & Immunology | C7708 (Arkansas) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Little Rock Allergy And Asthma Clinic Pa | 1658383633 | 8 |
News Archive
The global coronavirus disease COVID-19 pandemic is ravaging the world, affecting 185 countries and territories and infecting 2.4 million people. Now, a team of scientists aims to shed light on the variants of the novel coronavirus strains in India, showing how changes correspond to its transmission and how it causes disease.
The Wall Street Journal: "McDonald's Corp. has warned federal regulators that it could drop its health insurance plan for nearly 30,000 hourly restaurant workers unless regulators waive a new requirement of the U.S. health overhaul. The move is one of the clearest indications that new rules may disrupt workers' health plans as the law ripples through the real world.
Scientists have what could be some very bad news for disease-causing bacteria. All three major classes of antibiotics that kill infectious bacteria do so in part by ramping up the production of harmful free radicals, researchers report in the September 7, 2007, issue of Cell, a publication of Cell Press.
ACCESS PHARMACEUTICALS, INC. announced today that it initiated an internal pre-licensing program to confirm the utility of its proprietary Cobalamin (vitamin B12) platform technology for targeted delivery of siRNA therapies. The program is considered important because, despite the widely publicized potential of RNA therapy, researchers up to now have been stymied in their efforts to design a pharmaceutical product that efficiently transports siRNA therapeutics into the cells they are designed to inhibit or kill.
Cardiovascular disease will kill nearly 2.5 million people in the United States this year, according to the Centers for Disease Control. Over time, inflammation, collagen deposition and scar tissue formation can cause blood vessels to stiffen, a process called vascular fibrosis. Though researchers have known that the hormone aldosterone (Aldo) plays a role in this process, the precise mechanisms have been poorly understood.
› Verified 5 days ago
| Entity Name | Little Rock Allergy & Asthma Clinic Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1154360576 PECOS PAC ID: 1658383633 Enrollment ID: O20060609000125 |
News Archive
The global coronavirus disease COVID-19 pandemic is ravaging the world, affecting 185 countries and territories and infecting 2.4 million people. Now, a team of scientists aims to shed light on the variants of the novel coronavirus strains in India, showing how changes correspond to its transmission and how it causes disease.
The Wall Street Journal: "McDonald's Corp. has warned federal regulators that it could drop its health insurance plan for nearly 30,000 hourly restaurant workers unless regulators waive a new requirement of the U.S. health overhaul. The move is one of the clearest indications that new rules may disrupt workers' health plans as the law ripples through the real world.
Scientists have what could be some very bad news for disease-causing bacteria. All three major classes of antibiotics that kill infectious bacteria do so in part by ramping up the production of harmful free radicals, researchers report in the September 7, 2007, issue of Cell, a publication of Cell Press.
ACCESS PHARMACEUTICALS, INC. announced today that it initiated an internal pre-licensing program to confirm the utility of its proprietary Cobalamin (vitamin B12) platform technology for targeted delivery of siRNA therapies. The program is considered important because, despite the widely publicized potential of RNA therapy, researchers up to now have been stymied in their efforts to design a pharmaceutical product that efficiently transports siRNA therapeutics into the cells they are designed to inhibit or kill.
Cardiovascular disease will kill nearly 2.5 million people in the United States this year, according to the Centers for Disease Control. Over time, inflammation, collagen deposition and scar tissue formation can cause blood vessels to stiffen, a process called vascular fibrosis. Though researchers have known that the hormone aldosterone (Aldo) plays a role in this process, the precise mechanisms have been poorly understood.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Jim Mark Ingram, MD 18 Corporate Hill Drive, Suite 110, Little Rock, AR 72205-4565 Ph: (501) 224-1156 | Dr Jim Mark Ingram, MD 18 Corporate Hill Dr, Suite 110, Little Rock, AR 72205-4565 Ph: (501) 224-1156 |
News Archive
The global coronavirus disease COVID-19 pandemic is ravaging the world, affecting 185 countries and territories and infecting 2.4 million people. Now, a team of scientists aims to shed light on the variants of the novel coronavirus strains in India, showing how changes correspond to its transmission and how it causes disease.
The Wall Street Journal: "McDonald's Corp. has warned federal regulators that it could drop its health insurance plan for nearly 30,000 hourly restaurant workers unless regulators waive a new requirement of the U.S. health overhaul. The move is one of the clearest indications that new rules may disrupt workers' health plans as the law ripples through the real world.
Scientists have what could be some very bad news for disease-causing bacteria. All three major classes of antibiotics that kill infectious bacteria do so in part by ramping up the production of harmful free radicals, researchers report in the September 7, 2007, issue of Cell, a publication of Cell Press.
ACCESS PHARMACEUTICALS, INC. announced today that it initiated an internal pre-licensing program to confirm the utility of its proprietary Cobalamin (vitamin B12) platform technology for targeted delivery of siRNA therapies. The program is considered important because, despite the widely publicized potential of RNA therapy, researchers up to now have been stymied in their efforts to design a pharmaceutical product that efficiently transports siRNA therapeutics into the cells they are designed to inhibit or kill.
Cardiovascular disease will kill nearly 2.5 million people in the United States this year, according to the Centers for Disease Control. Over time, inflammation, collagen deposition and scar tissue formation can cause blood vessels to stiffen, a process called vascular fibrosis. Though researchers have known that the hormone aldosterone (Aldo) plays a role in this process, the precise mechanisms have been poorly understood.
› Verified 5 days ago
Dr. Donna Melissa Graham, M.D. Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 500 S University Ave, Suite 215, Little Rock, AR 72205 Phone: 501-420-1085 Fax: 501-420-1457 | |
Eddie W Shields, M.D. Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 5 Executive Center Ct, Little Rock, AR 72211 Phone: 501-227-5210 Fax: 855-656-7325 | |
Dr. Deanna N. Ruddell, MD Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 16101 Cantrell Rd Ste 104, Little Rock, AR 72223 Phone: 501-425-0322 | |
Lindsay M. Still, M.D. Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 5 Executive Center Ct, Little Rock, AR 72211 Phone: 501-227-5210 Fax: 855-656-7325 | |
Dr. Meredith Dilley, M.D. Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 10201 Kanis Rd, Little Rock, AR 72205 Phone: 501-227-5050 | |
Kelly D Burks, MD Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 5 Executive Center Ct, Little Rock, AR 72211 Phone: 501-227-5210 Fax: 855-656-7325 |